Inactive Instrument
CEREP Share Price Euronext Paris
Stocks
FR0004042232
Biotechnology & Medical Research
|
End-of-day quote
Euronext Paris
|
||
| - EUR | - |
|
| 08-25 | Lotus Bakeries, the most expensive speculoos on the (stock) market in Europe |  |
| 04-29 | Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 91.3M 103M 85.44M 77.44M 146M 9.91B 147M 1.03B 399M 5.06B 386M 378M 16.26B | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 70.26M 79.15M 65.75M 59.6M 113M 7.63B 113M 790M 307M 3.89B 297M 291M 12.51B | EV / Sales 2024 |
2.02x | EV / Sales 2025 | 1.67x |
| Free-Float |
4.22% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Vielliard
CEO | Chief Executive Officer | - | 10/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Ratcliffe
CHM | Chairman | - | 10/08/2023 |
Damien Vielliard
BRD | Director/Board Member | - | 22/05/2024 |
Rodolphe Simonot
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.16% | +4.16% | +49.37% | +94.17% | 74.69B | |
| -0.57% | -2.03% | +22.18% | +77.64% | 58.81B | |
| +0.45% | +0.42% | +6.92% | +34.64% | 48.45B | |
| -3.76% | -2.25% | +329.09% | +698.20% | 42.84B | |
| -2.30% | -3.35% | +26.81% | +30.88% | 42.79B | |
| +0.31% | -0.68% | +5.30% | +108.64% | 41.25B | |
| -0.11% | +1.96% | +9.19% | +52.66% | 31.13B | |
| -2.07% | +1.16% | +35.00% | +26.28% | 30.28B | |
| -1.96% | -2.88% | -8.97% | -13.92% | 24.05B | |
| Average | -0.66% | -0.25% | +52.77% | +123.24% | 43.81B | |
| Weighted average by Cap. | -0.16% | -0.54% | +55.60% | +129.58% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 40.49M 45.61M 37.89M 34.34M 64.86M 4.4B 65.33M 455M 177M 2.24B 171M 168M 7.21B | 41.1M 46.3M 38.46M 34.86M 65.84M 4.46B 66.31M 462M 180M 2.28B 174M 170M 7.32B |
| Net income | 7.15M 8.06M 6.7M 6.07M 11.46M 777M 11.54M 80.41M 31.28M 396M 30.25M 29.6M 1.27B | 4.78M 5.39M 4.48M 4.06M 7.66M 519M 7.72M 53.75M 20.91M 265M 20.22M 19.79M 852M |
| Net Debt | -17.25M -19.44M -16.15M -14.63M -27.64M -1.87B -27.84M -194M -75.42M -956M -72.95M -71.39M -3.07B | -21.03M -23.7M -19.68M -17.84M -33.7M -2.28B -33.94M -236M -91.95M -1.17B -88.94M -87.04M -3.75B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
